Table 1 The relationship between miR-133b expression and clinicopathological characterisics of bladder cancer
From: MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1
| Charactistics | n = 41 | MiR-133b level | Pvalue | |
|---|---|---|---|---|
| High (%) | Low (%) | |||
| Gender | ||||
| Male | 29 | 11(64.5) | 18(75) | 0.475a |
| Female | 12 | 6(35.3) | 6(25) | 0.187a |
| Clinical stage | ||||
| Ta-T1 (non-invasive) | 24 | 12 | 012 | |
| T2-T4 (invasive) | 17 | 5 | 12 | 0.003b* |
| Pathological grading | ||||
| Low level | 19 | 13 | 6 | |
| High level | 21 | 4 | 17 | |
| Neoplasm recurrence | ||||
| Early-onset | 25 | 10 | 15 | 0.812a |
| Recurrent | 16 | 7 | 9 | |